Susquehanna International Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-215,124
| Closed | -$4.06M | – | 11232 |
|
|
2019
Q3 | $4.06M | Buy |
215,124
+130,854
| +155% | +$1.5M | ﹤0.01% | 3015 |
|
|
2019
Q2 | $992K | Buy |
+84,270
| New | +$1.02M | ﹤0.01% | 5680 |
|
|
2019
Q1 | – | Sell |
-24,728
| Closed | -$320K | – | 10395 |
|
|
2018
Q4 | $253K | Buy |
+24,728
| New | +$317K | ﹤0.01% | 7319 |
|
|
2018
Q3 | – | Sell |
-140,071
| Closed | -$2.53M | – | 10733 |
|
|
2018
Q2 | $2.21M | Buy |
140,071
+113,373
| +425% | +$1.72M | ﹤0.01% | 3838 |
|
|
2018
Q1 | $339K | Sell |
26,698
-47,492
| -64% | -$687K | ﹤0.01% | 7419 |
|
|
2017
Q4 | $849K | Buy |
74,190
+59,634
| +410% | +$666K | ﹤0.01% | 5567 |
|
|
2017
Q3 | $178K | Buy |
+14,556
| New | +$152K | ﹤0.01% | 8103 |
|
|
2017
Q1 | – | Sell |
-12,124
| Closed | -$268K | – | 10510 |
|
|
2016
Q4 | $252K | Buy |
+12,124
| New | +$315K | ﹤0.01% | 8268 |
|
|
2016
Q1 | – | Sell |
-43,277
| Closed | -$1M | – | 10012 |
|
|
2015
Q4 | $1.43M | Sell |
43,277
-62,506
| -59% | -$2.11M | ﹤0.01% | 4699 |
|
|
2015
Q3 | $3.46M | Buy |
105,783
+59,396
| +128% | +$2.53M | ﹤0.01% | 3250 |
|
|
2015
Q2 | $2.46M | Buy |
46,387
+18,606
| +67% | +$677K | ﹤0.01% | 4264 |
|
|
2015
Q1 | $802K | Buy |
+27,781
| New | +$762K | ﹤0.01% | 6199 |
|
|
2014
Q3 | – | Sell |
-11,251
| Closed | -$226K | – | 10213 |
|
|
2014
Q2 | $226K | Buy |
+11,251
| New | +$158K | ﹤0.01% | 8864 |
|